Search Results

You are looking at 61 - 70 of 1,293 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Kevin S. Scher, Juan-Sebastian Saldivar, Michael Fishbein, Alberto Marchevsky, and Karen L. Reckamp

scan after 8 weeks of erlotinib showed continued significant decrease in the right upper lobe mass and mediastinal lymphadenopathy. Table 1 Tissue Biopsy Characteristics In April 2010, the patient underwent right pneumonectomy with lymph

Full access

Saby George, Roberto Pili, Michael A. Carducci, and Jenny J. Kim

in search of biomarker of response to IL-2 that can be validated in subsequent studies. Table 1 Response by Baseline Characteristics The therapeutic armamentarium for metastatic RCC considerably expanded in the past several years with

Full access

Kan Wu, Xu Liu, Zhihong Liu, Yiping Lu, Xianding Wang, and Xiang Li

nonmetastatic ACC using a large population-based database. In addition, we sought to identify a subset of patients with ACC who may be more likely to benefit from adjuvant radiation based on their tumor characteristics. Patients and Methods Study

Full access

Christopher P. Chung, Carolyn Behrendt, Louise Wong, Sarah Flores, and Joanne E. Mortimer

classified according to the IIQ-7 score as major (33–99), moderate (5–29), or no impact (0). Statistical Analyses For this exploratory study, statistical significance ( P <.05) was unadjusted for multiple hypothesis testing. Demographic characteristics (age

Full access

Melissa S.Y. Thong, Daniel Boakye, Lina Jansen, Uwe M. Martens, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, and Volker Arndt

of demographic and clinical characteristics by CCIS were tested for statistical significance using either an analysis of variance for continuous variables or a chi-square test for categorical variables. We used multivariable linear regression to

Full access

Kathryn P. Lowry, Katherine A. Callaway, Janie M. Lee, Fang Zhang, Dennis Ross-Degnan, J. Frank Wharam, Karla Kerlikowske, Karen J. Wernli, Allison W. Kurian, Louise M. Henderson, and Natasha K. Stout

enrollment. Results Cohort Selection and Characteristics Of 27,456,015 women enrolled from 2004 to 2016, we identified 141,672 aged 40 to 64 years with evidence of a personal breast cancer history meeting our inclusion/exclusion criteria

Full access

Matthew P. Banegas, Donna R. Rivera, Maureen C. O’Keeffe-Rosetti, Nikki M. Carroll, Pamala A. Pawloski, David C. Tabano, Mara M. Epstein, Kai Yeung, Mark C. Hornbrook, Christine Lu, and Debra P. Ritzwoller

standards. 22 VTR data were obtained via chart review by trained abstractors and included data associated with health service use and clinical, treatment, and tumor characteristics. The VDW pharmacy files provided data on national drug code

Full access

Samuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, Noam F. Ponde, Andrea Gombos, Vicki Paterson, Florentine Hilbers, Larissa Korde, Anna Manukyants, Amylou Dueck, Christian Maurer, Martine Piccart, Alvaro Moreno-Aspitia, Christine Desmedt, Serena Di Cosimo, and Evandro de Azambuja

original ALTTO trial. 10 Statistical Considerations Patient baseline characteristics were compared with respect to BMI category (underweight, normal weight, overweight, obese) using the chi-square test. Weight change was calculated as a percentage (by

Full access

Heidi Ko, Yaser Baghdadi, Charito Love, and Joseph A. Sparano

for categorical variables. Association Between Clinical Characteristics and Upstaging Frequencies Associations between clinical characteristics and upstaging frequencies were assessed using the Fisher exact test for categorical variables and the

Full access

Abi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, Ning Liu, Danielle Blunt, Shabbir Alibhai, Anca Prica, and Matthew C. Cheung

frequency and percentages where appropriate. The Student t test was used to compare baseline characteristics, frailty scores, and chemoimmunotherapy cycles received between frail and nonfrail patients. The chi-square test was used to compare categorical